DC
District Of Columbia Council Bill PR25-0287

District Of Columbia 2023-2024 Regular Session

District Of Columbia Council Bill PR25-0287 Compare Versions

Only one version of the bill is available at this time.
OldNewDifferences
11 MURIEL BOWSER
22 MAYOR
33 June 15, 2023
44 The Honorable Phil Mendelson
55 Chairman
66 Council
77 of the District of Columbia
88 John
99 A. Wilson Building
1010 1350Pennsylvania Avenue,
1111 NW, Suite 504
1212 Washington, DC 20004
1313 Dear Chairman Mendelson:
1414 In accordance with section 2
1515 ofthe Confirmation Act of 1978, effective March 3, 1979 (D.C. Law
1616 2-142; D.C. Official
1717 Code§ 1-523.01), and pursuant to section 4603 of the Child Fatality Review
1818 Committee Establishment Act
1919 of 2001, effective October 3, 2001 (D.C. Law 14-28; D.C. Official
2020 Code§ 4-1371.03), I am pleased to nominate the following person:
2121 Dr. Jacqueline Francis
2222 12th Street
2323 NE
2424 Washington, D.C. 20002
2525 (Ward
2626 6)
2727 for reappointment as a community representative member of the Child Fatality Review Committee,
2828 for
2929 a term to end July 16, 2025.
3030 Enclosed you will find biographical information detailing the experience
3131 of the above­
3232 mentioned nominee, together with a proposed resolution
3333 to assist the Council during the
3434 confirmation process.
3535 I would appreciate the Council's earliest consideration of this nomination for confirmation.
3636 Please do not hesitate
3737 to contact me, or Steven Walker, Director, Mayor's Office of Talent
3838 and Appointments, should the Council require additional information. 1
3939 2
4040 3
4141 4
4242 5
4343 6
4444 7
4545 8
4646 9
4747 10
4848 11
4949 12
5050 13
5151 14
5252 15
5353 ~~~
5454 at the request of the Mayor
5555 A PROPOSED RESOLUTION
5656 IN THE COUNCIL
5757 OF THE DISTRICT OF COLUMBIA
5858 16 To confirm the reappointment of Dr. Jacqueline Francis to the Child Fatality Review Committee.
5959 17
6060 18 RESOLVED, BY THE COUNCIL OF THE DISTRICT OF COLUMBIA, That this
6161 19 resolution may be cited as the "Child Fatality Review Committee Dr. Jacqueline Francis
6262 20 Confirmation Resolution of 2023".
6363 21
6464 22 Sec. 2. The Council of the District of Columbia confirms the reappointment of:
6565 23
6666 24 Dr. Jacqueline Francis
6767 25 12th Street NE
6868 2.6 Washington, D.C. 20002
6969 27 (Ward 6)
7070 28
7171 29 as a community representative member of the Child Fatality Review Committee, pursuant to
7272 30 section 4603 of the Child Fatality Review Committee Establishment Act of 2001, effective
7373 31 October 3, 2001 (D.C. Law 14-28; D.C. Official Code§ 4-1371.03), and in accordance with
7474 32 section 2 of the Confirmation Act of 1978, effective March 3, 1979 (D.C. Law 2-142; D.C.
7575 33 Official Code§ 1-523.01), for a term to end July 16, 2025.
7676 34 Sec. 3. The Council of the District of Columbia shall transmit a copy of this resolution,
7777 35 upon its adoption, to the nominee and to the Office of the Mayor.
7878 36 Sec. 4. This resolution shall take effect immediately.
7979 37 Jacqueline Nicole Francis, MD, MPH
8080 OBJECTIVES: To serve as a health advocate.
8181 WORKEXPERIENCE
8282 Acting Chief Pediatric Medical Officer Silver Spring, l\,ID .Apr. 2012-2013
8383 Serving
8484 as chief pediatric physician expert in the Center for Devices and Radiological Health. Represents the
8585 Center
8686 on pediatri<:: medical device related issues. Drafting guidance documents related to Pediatric Medical
8787 Device Tracking, Custom Devices,
8888 HDE legislation and Extrapolation of adult data for pediatric device
8989 indications. Coordinates initiatives and oversees execution ofactivities related to pediatric device issues.
9090 Planned and
9191 exe<::uted the Rare Diseases Workshop to address pediatric issues related to the development of
9292 medical devices used for rare diseases Qanuary 8, 2014). Works with the Pediatric Device Consortium (FDA)
9393 to conduct workshops for grant recipients, collaborated
9494 on the drafting of the grant application/FR notice
9595 and will oversee selection
9696 of grant recipients. Represents FD.A and expert on pediatric device development
9797 and regulation.
9898 Medical Officer Silver Spring, MD Sept. 2006-to date
9999 Clinical consultant
100100 to Plastic: Surgery and Reconstruction Branch of the Office of Device Evaluation in the
101101 Center for Devices
102102 and Radiological Health at the Food and Drug ..Administration. This division evaluates
103103 and
104104 dears plastic surgery diagnostic and therapeutic devices. Served as clinical consultant to other branches
105105 for a variety
106106 of devices including neurological, orthopedic, and general surgery devices with pediatric
107107 indications.
108108 Collaborative Reviewer Rockville, MD 2007-2010
109109 Served
110110 as a collaborative reviewer \,Vith the Office of Patient Safety with the Medsun pilot project and
111111 working to launch
112112 KIDNET (adverse event reporting system for pediatric devices). Represented FDA,
113113 Presented abstract poster on the K.IDNET program at the American Academy of Pediatrics Annual meeting
114114 October 2008. to educate pediatricians about the
115115 KIDNET program.
116116 Attending Physician Washington, DC Jan. 2005 to date
117117 KIDS Mobile Medical Clinic pediatrician working in medically underserved areas
118118 of Washington, DC each
119119 Friday as primary pediatrician. Also serving
120120 on the teaching staff supervising training of residents and
121121 medical students. Credentialed at
122122 Georgetown University Hospital.
123123 Medical Officer
124124 Rockville, MD 2004-Sept 2006
125125 Clinical consultant
126126 to the :tvficrobiology and Chemistry divisions in the Office of In Vitro Diagnostic Device
127127 Evaluation and Safety in the Center for Devices and Radiological Health at the
128128 Food and Drug
129129 Administration. This division evaluates and clears infectious disease and chemistry in vitro diagnostic
130130 devices. Appointed
131131 as the Oirector of the Patient Safety Committee, which monitors safety of devices in
132132 post marketing.
133133 Attending Physician Washington, DC 4-\pr. 2004 to date
134134 Well baby nursery and special care nursery attending physican. Admitting, discharging ,and identifying
135135 neonates
136136 at risk for illness and congenital health issues. Credentialed at Sibley and Georgetown University
137137 Hospitals.
138138 Attending Physician Washington, DC
139139 Children's Health Project
140140 of DC pediatrician working in medically underserved areas ofWashington, DC.
141141 EDUCATION
142142 Johns Hopkins University Medical Center Baltimore, MD 2001-2003 Resident in Preventive Medicine. Successfully completed rotations at Occupational Safety and Health
143143 Administration (OSHA) Dept.
144144 of Occupational Medicine); the District of Columbia Dept. of Health
145145 (Division
146146 of Communicable Diseases); the US Food and Dtug Administration (FDA, Dept. of Vaccine
147147 Safety, Smallpox Vaccine Surveillance Team); the Department
148148 of Juvenile Justice (DJJ) Health division;
149149 and the
150150 \XIHO /JHU dept. of Infectious Diseases in Cameroon on measles surveillance and prevention.
151151 Johns Hopkins University Baltimore, MD 2001-2003
152152 Completed a.Masters
153153 in Public Health during the preventive medicine residency specializing in Health Policy
154154 and Management.
155155 Georgetown University Washington, DC 2000-2002
156156 Clinical Pha1macology Fellowship. Trained extensively in drug interaction, metabolism and the specialty
157157 of
158158 drug management. Focused on Natural Products. Conducted clinical trial on effect of St. John's Wort on
159159 CYP450 Isoenzyrnes.
160160 Georgetown University Hospital Washington, DC 1997-2000
161161 Resident in Pediatrics. Electives completed during residency included; Pediatric Gastroenterology, Pediatric
162162 Infectious Diseases,
163163 Pediat11c Cardiology (Fairfax Hospital, VA), Pediatric Endocrinology (Howard
164164 University Hospital,DC), Child Advocacy (DC Action for Children), Pediatric Development
165165 (PG Hospital,
166166 MD), International Medicine (Mulago Hospital, Kampala, Uganda).
167167 Temple University School of Medicine
168168 Doctor of Medicine Degree
169169 Philadelphia, PA
170170 Cornell University Ithaca, NY
171171 Bachelors of Science Degree, majored in Nut.ritional Biochemistry.
172172 Philadelphia High School for Girls
173173 Received High School diploma
174174 Shaw High School
175175 RESEARCH EXPERIENCE
176176 Philadelphia, PA
177177 Cleveland,
178178 0 H
179179 Bill Gates Foundation/Johns Hopkins University Yaounde, Cameroon
180180 1993-1997
181181 1987-1989
182182 1985-1987
183183 June-Sept. 2003
184184 Worked with local branch
185185 of the \VI-IO and the Cameroon national vaccine program (PEV) to evaluate the
186186 effectiveness
187187 of the country's measles infectiort surveillance system. Prov"ided recomtnendations to the
188188 Cameroonian Ministry
189189 of Public Health and provided data to JHU to help determine the accuracy of data
190190 generated by
191191 PEV /\XIHO. Traveled extensively through Cameroon.
192192 Food and Drug Administration Rockville, MD Feb-Mar., 2003
193193 Analysis
194194 of adverse events reported to VAERS for the Smallpox Vaccine from December 13, 2002-March
195195 2003. Findings were presented to the CDC and
196196 FDA vaccine safety teams as well as to a Congressional
197197 Subcommittee. Advisor: Robert Ball, MD.
198198 Georgetown University Hospital Washington, DC 2001-2003
199199 Effect
200200 ofSt. John's Wort Extract on CYP450 Isoenzymes and Natural Product use in the Pediatric
201201 population
202202 Case Western Reserve School of Medicine
203203 DNA Transplarttation
204204 Clevehrnd,
205205 0 H Summer, 1992 Temple University School of Medicine Philadelphia, P21. Summer,1991
206206 DNA sequencing of Retinoic Acid Binding Protein. Advisor: Diane Soprano, PhD
207207 Temple University School of Medicine Philadelphia, P.A Summer, 1988
208208 Replication
209209 of neonate cardiocytes using Norepinephrine Advisor: Thomas Marino, PhD.
210210 PUBLICATIONS
211211 Leveraging Existing Clinical Data for Extrapolation to Pediatric Uses of Medical Devices, CDRH Guidance
212212 document, Issuance Pending Spring, 2015
213213 http:/ /W\vw.fda.gov/ucm/groups/fdagov-public/@fdagov-1neddev­
214214 gen/ documents/ document/ ucm444591.pdf
215215 Pediatric Clinics
216216 of North America, Safety and Reliability in Pediatrics, "FDA working to ensure the safety of
217217 medical devices used in the pediatric population". Volume 59, Issue 6, December 2012, Pages 1355-1366.
218218 http://www.sciencedirect.com/science/article/pii/S0031395512001307
219219 OTHER ACTIVITIES
220220 Cornell Human Ecology Alumni Association Ithaca, NY 2010 to 2015
221221 Elected
222222 in 2009 to serve as member of the Board of Directors for HE.A,-\. Participates in quarterly meetings
223223 either
224224 on campus or by telephone to discuss issues related to the college of Human Ecology, and serving on the
225225 committee, which reviews HE.A.A Student
226226 Grant applications.
227227 Unity Health Care Washington, DC 2010 to 2015
228228 Serving
229229 on the Board of Directors of Unity Health Care, which is a DC, based health care conglomerate,
230230 which provides medical
231231 and social services to DC residents regardless of ability to pay. ~-\.ttends monthly BOD
232232 meetings. Chair of Continuous Quality Improvement Committee since 2012)
233233 Step Mrika! Washington, DC 2008 to date
234234 Se.ryed
235235 on the planning committee for the Annual Home Performance Series and currently serving on the
236236 Board of Directors as Chairperson. Served as Vice-Chair of the BOD 2010-2011 and Chair of the BOD
237237 from 2012-2017.
238238 FRESH Student ExtemProgram Washington, DC 2007-2010
239239 Scheduled profe.ssional shadowing experience with current Cornell Student during academic breaks.
240240 Cornell Alumni Student Mentoring Program 2006 to date
241241 Virtual
242242 mentor to two currently enrolled Cornell students and three recent alumni. Visit with students either
243243 on campus or in DC to serve as mentor and advisor. Currently Serving as mentor to S Cornell Alumni.
244244 Mayor Fenty's Health Policy Transition Team Washington, DC 2006-2007
245245 Served
246246 on the Health Policy Transition team From November, 2006-February, 2007 for DC J\,1ayor Adrian
247247 Fenty
248248 and assisted in the drafting of '~The Parameters of Health" which outlined health policy proposals and
249249 priorities
250250 to achieve .Adrian Fenty's ''Vision for a Healthy City".
251251 Cornell Club of Washington
252252 Board Member
253253 Washington,
254254 DC 2005-2006 Cornell Black Alumni Associatiort Washington, DC 2004-2011
255255 Member. Served as Reg1onal Co-Chair
256256 in 2006.
257257 Institute for Urban Living Washington, DC 2004-2006
258258 Member of the Board of Directors. Organization provides support services for the District's homeless
259259 population.
260260 College Bound Washington, DC 2001-2016
261261 Tutot and mentor. Selected as Mentor of the Year, 2003. Nominated for 111e Washington Redskins
262262 Community Quarterback.Award. Currently serving
263263 on the Board of Directors (2006-to date) as Board
264264 Secretary (since 2012) ..
265265 Also serving as a virtual mentor to a college graduate.
266266 Cornell Alumni Ambassadors Admissions Network Washington, DC
267267 Inte.rview prospective applicants to Cornell and participate in college fairs.
268268 1995-to date
269269 Manuscript Reviewer Washington, DC 2001-to date
270270 Review manuscripts
271271 on behalf of ~iichael Stein, MD for Clinical Pharmacology and Therapeutics scientific
272272 journal.
273273 Dream Academy
274274 Mentor
275275 SAT prep class instructor
276276 Big Friends
277277 Tutored third and fourth grader students
278278 HONORS AND ACHIEVEMENTS
279279 Washington, DC
280280 Philadelphia, PA
281281 Philadelphia, PA
282282 2000-2002
283283 1994-1997
284284 1993-1995
285285 ODE Award of Recognition June 2017
286286 This award recognized tireless efforts to expedite
287287 the classification of unclassified wound dressings and to
288288 prepare for progress briefings to Center and Agency management.
289289 ODE Award of Recognition June 10, 2017
290290 This award recognized excellence in Agency "vide collaboration to promote safe use of soft tissue filler devices.
291291 ODE Award of Recognition August 2016
292292 This award r.ecognized excellence in consults
293293 and development and dissemination of policies related to devices
294294 intended for pediatric use.
295295 ODE Award of Recognition August 2015
296296 This
297297 award recognized excellence in consults and regulatory support and was awarded by the ODE Office
298298 director.
299299 Commissioner's Award ofExcellence August, 2014
300300 This award recognized contributions
301301 and accomplishments in conducting and executing the Pediatric Device
302302 Consortia
303303 Grant process.
304304 ODE Excellence in Premarket Review Team Award July 2014
305305 This award recognized significant accomplishment in supporting the mission of CDRH in working with the
306306 Aesthe.tic Clinical Trials Team.
307307 CDRH Guidance/Policy/Regulation Development Excellence Award June, 2014
308308 For excellence in writing guidance on custom devices that incorporates the requirements and revisions of the
309309 FDA Safety and Innovations Act of 2012. FDA Ho11or Award J1.1ne, 2014
310310 This award recognized superior achievement
311311 of the Agency's mission through teamwork, partnership, shared
312312 responsibility,
313313 o:r fostering collaboration and coalition to achieve F DA goals related to the planning ancl
314314 implementation of the Rare Disease Public Workshop.
315315 Reward and Recognition FDA/CDRH/ODE August 2011
316316 For exceptional scientific and regulatory perfo1mance while reviewing two de novo applications.
317317 Reward and Recognition FDA/CDRH/0D E August 2011
318318 For exceptional scientific and regulatory performa11ce, while reviewing Contura, Inc's Aquamid Dermal Filler
319319 PM.A.
320320 Reward and Recognition FDA/CDRH/ODE August2011
321321 For exceptional scientific and regulatory performance during the preparation and editing of modifications to
322322 the Breast Implant patient and physician labels to include .ALCL information.
323323 Reward and Recognition FDA/CDRH/ODE Sept. 2010
324324 For exceptional scientific and regulatory perfo1mance while acting as clinical reviewer and medical advisor to
325325 the breast implant review team for bteast implant PfvL\s and medical issues related to breast implants.
326326 FDA Outstandiilg Service Award June, 2010
327327 This award is in recognition
328328 of dedication to excellence in accomplishing the mission of the CDRH as a
329329 member of the Wound Dressing Group.
330330 Reward and Recognition FDA/CDRII/ODE Sept. 2009
331331 For work on perfo,;ming complicated review of tiss1.1e fillers combined with the drug lidocaine.
332332 Director's Special Citation., FDA/CDRH/OSB
333333 Recognized for work on the launch of the KidNet pilot program
334334 Special Recognition Award, FDA/CDRH/OIVD
335335 Recognition for work with the review team for Continuous Glucose Monitors
336336 Group Recognition Award, FDA/CDRH/OSB
337337 Recognition for work with the Collaborative Reviewers Team.
338338 June, 2008
339339 June,2008
340340 June,2008
341341 Reward and Recognition FDA/CDRH/ODE March, 2005
342342 For medical consulting contributions to the review of In Vitro diagnostic Devices and Leadership of the
343343 OIVD Patient Safety Team.
344344 Bill Gates FoUildation Grant
345345 NIH Fellowship Award
346346 National Minority Fellowship Award
347347 Quill and
348348 Dagger Senior Honor Society
349349 Cornell Tradition Fellowship
350350 Office
351351 of Minority Affairs Scholarship
352352 White Williams Scholarship
353353 for In.t.ernational Affairs
354354 .ADMITTING PRIVLIGES
355355 2003
356356 2001-2002
357357 1994-1997
358358 1992
359359 1990-1993
360360 1989-1993
361361 1988-1989 Georgetown University Hospital and Sibley IV1emorial Hospital. * * * WE ARE
362362 WASl-!INGTON
363363 oc
364364 Executive Office of the Mayor -Office of Talent and Appointments
365365 John A. Wilson Building I 1350 Pennsylvania Avenue, Suite 600 I Washington, DC 20004
366366 """4~1: ...... o11~
367367 ,.~
368368 Dr. Jacqueline Francis, MD
369369 Dr. Jacqueline Francis is a pediatrician and Medical Officer at the Food
370370 and Drug Administration (FDA). She has been a member
371371 of the Child
372372 Fatality Review Committee since 2017.
373373 Dr. Francis began her career
374374 in the FDA's Office ofln-Vitro Diagnostic
375375 Devices, where she worked
376376 in the microbiology branch as a clinical
377377 consultant.
378378 In her current office, the Office of Device Evaluation in the
379379 Division
380380 of Surgical Devices, she specializes in policy, regulation, and
381381 clinical protocol design
382382 of plastic and reconstructive surgery devices as
383383 well as pediatric devices. Dr. Francis also serves as an Attending
384384 Physician with the KIDS Mobile Clinic
385385 of Medstar Hospital and
386386 previously served at the Hoya Clinic, which serves the shelter patients
387387 at DC General Campus.
388388 A Ward 6 resident, Dr. Francis received a Bachelor
389389 of Science in Nutritional Biochemistry from
390390 Cornell University, a Doctor
391391 of Medicine from the Temple University School of Medicine, and a
392392 Master
393393 of Public Health from the Johns Hopkins University Bloomberg School of Public Health.
394394 * * * GOVERNMENT OF THE DISTRICT OF COLUMBIA
395395 E~ecutive Office of Mayor Muriel Bowser
396396 * * * WEARE
397397 WASI-IINGTON
398398 oc
399399 Office of the General Counsel to the Mayor
400400 To:
401401 From:
402402 Date:
403403 Subject:
404404 Tommy Wells, Steve Walker
405405 Betsy Cavendish
406406 April
407407 5, 2023
408408 Legal sufficiency review of Resolutions nominating Dr. Jacqueline Francis, Dr.
409409 Cheryl Williams and Kristen Constantine as community representative members
410410 of the Child Fatality Review Committee
411411 This is to Certify that this office has reviewed the above-referenced resolution and
412412 found it to be legally unobjectionable. If you have any questions in this regard, please do not
413413 hesitate to call Vanessa Careiro, Deputy General Counsel, Executive Office of the Mayor, at
414414 202-724-1303, or me at 202-724-7681.
415415 Elizabeth
416416 A. (Betsy) Cavendish
417417 The John A. Wilson Building • 1350 Pennsylvania Avenue, NW • Suite 300 • Washington, D. C. 20004 • Office (202) 724-7681